Selective RET inhibitors shift the treatment pattern of RET fusion-positive NSCLC and improve survival outcomes. - Lu, Chang; Wei, Xue-Wu; Zhang, Yi-Chen; Chen, Zhi-Hong; Xu, Chong-Rui; Zheng, Ming-Ying; Yang, Jin-Ji; Zhang, Xu-Chao; Zhou, Qing (Journal of Cancer Research & Clinical Oncology, 2023)